Sign In
Buy ARVN
$8.03
-0.270 (-3.25%)
At Close: Jul 31, 2026
- Describes the first evidence of clinical benefit for PROTAC® protein degraders, a novel therapeutic modality - - Data to be presented during the 2020 American Society of.
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
How Arvinas (ARVN) Stock Stands Out in a Strong Industry
12:54pm, Tuesday, 12'th May 2020
Arvinas (ARVN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Arvinas, Inc. (ARVN) Upgraded to Buy: Here's What You Should Know
04:00pm, Tuesday, 05'th May 2020
Arvinas, Inc. (ARVN) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Arvinas Inc (NASDAQ:ARVN) Short Interest Up 8.2% in April
09:26am, Saturday, 02'nd May 2020
Arvinas Inc (NASDAQ:ARVN) was the target of a large increase in short interest in April. As of April 15th, there was short interest totalling 2,900,000 shares, an increase of 8.2% from the March 31st
Arvinas Inc (NASDAQ:ARVN) Given Consensus Recommendation of "Buy" by Brokerages
08:46am, Saturday, 02'nd May 2020
Shares of Arvinas Inc (NASDAQ:ARVN) have been assigned a consensus rating of “Buy” from the thirteen brokerages that are currently covering the company, MarketBeat reports. Two analysts have rated
Q2 2020 Earnings Estimate for Arvinas Inc Issued By Wedbush (NASDAQ:ARVN)
07:16am, Saturday, 02'nd May 2020
Arvinas Inc (NASDAQ:ARVN) – Analysts at Wedbush raised their Q2 2020 earnings per share estimates for Arvinas in a research report issued on Tuesday, April 28th. Wedbush analyst R. Driscoll now expe
Analysts Are Upgrading Arvinas, Inc. (NASDAQ:ARVN) After Its Latest Results
10:33am, Friday, 01'st May 2020
As you might know, Arvinas, Inc. (NASDAQ:ARVN) just kicked off its latest first-quarter results with some very strong...
Analysts Are Upgrading Arvinas, Inc. (NASDAQ:ARVN) After Its Latest Results
10:32am, Friday, 01'st May 2020
Arvinas, Inc. (NASDAQ:ARVN) defied analyst predictions to release its quarterly results, which were ahead of market...
5AM Venture Management LLC Cuts Position in Arvinas Inc (NASDAQ:ARVN)
08:48am, Friday, 01'st May 2020
5AM Venture Management LLC lessened its holdings in Arvinas Inc (NASDAQ:ARVN) by 27.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Excha
Arvinas (NASDAQ:ARVN) Hits New 52-Week High Following Strong Earnings
07:34am, Friday, 01'st May 2020
Shares of Arvinas Inc (NASDAQ:ARVN) hit a new 52-week high during mid-day trading on Wednesday following a better than expected earnings announcement. The company traded as high as $58.00 and last tra
Q2 2020 EPS Estimates for Arvinas Inc Cut by Piper Sandler (NASDAQ:ARVN)
06:56am, Friday, 01'st May 2020
Arvinas Inc (NASDAQ:ARVN) – Investment analysts at Piper Sandler reduced their Q2 2020 EPS estimates for shares of Arvinas in a research report issued to clients and investors on Tuesday, April 28th
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
11:19am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu
Traders Buy Large Volume of Arvinas Call Options (NASDAQ:ARVN)
07:22am, Thursday, 30'th Apr 2020
Arvinas Inc (NASDAQ:ARVN) was the recipient of unusually large options trading on Wednesday. Stock investors bought 2,102 call options on the stock. This is an increase of 2,316% compared to the typic
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
12:00am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 29)
• Arvinas Inc (NASDAQ...
